2017 annual financial data
Castle Biosciences, Inc. 2017 Operating margin
Castle Biosciences, Inc. 2017 operating margin with verified reported values.
Direct answer
Operating margin was -79.25%.
Operating income was -10,899,676 USD and net income was -12,369,529 USD.
Operating cash flow was -12,233,587 USD.
Get free Castle Biosciences, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,753,912 USD
- Operating income
- -10,899,676 USD
- Net income
- -12,369,529 USD
- Operating cash flow
- -12,233,587 USD